| |
| |
|
| Insider
Information: |
Pien Howard H |
| Relationship: |
Director |
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
45,457 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,274 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
45,457 |
|
|
| Total
Value |
$17,274 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunogen Inc |
IMGN |
Director |
2009-12-28 |
0 |
2007-05-16 |
0 |
Premium* |
|
|
Viropharma Inc |
VPHM |
Director |
2014-01-24 |
0 |
2013-02-22 |
0 |
Premium* |
|
|
Juno Therapeutics, Inc. |
JUNO |
Director |
2018-03-05 |
0 |
|
0 |
Premium* |
|
|
Aceragen, Inc |
ACGN |
Director |
2020-10-01 |
45,457 |
2019-01-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-10-01 |
4 |
A |
$2.25 |
$12,562 |
D/D |
5,583 |
45,457 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-07-01 |
4 |
A |
$1.79 |
$12,562 |
D/D |
7,018 |
39,874 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-04-01 |
4 |
A |
$1.28 |
$12,372 |
D/D |
9,666 |
32,856 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-01-02 |
4 |
A |
$1.85 |
$12,562 |
D/D |
6,790 |
23,190 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2019-10-01 |
4 |
A |
$2.67 |
$12,309 |
D/D |
4,610 |
16,400 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2019-07-01 |
4 |
A |
$2.61 |
$11,664 |
D/D |
4,469 |
11,790 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2019-04-01 |
4 |
A |
$2.59 |
$11,375 |
D/D |
4,392 |
7,321 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2019-01-02 |
4 |
A |
$3.52 |
$10,310 |
D/D |
2,929 |
2,929 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-03-05 |
4 |
D |
$87.00 |
$439,350 |
D/D |
(5,050) |
0 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-03-05 |
4 |
D |
$87.00 |
$9,708,069 |
D/D |
(111,587) |
5,050 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-02-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,162 |
116,637 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-02-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,251 |
117,799 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
417 |
130,050 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-12-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
129,633 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
447 |
154,633 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
640 |
154,186 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
865 |
153,546 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
995 |
152,681 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
675 |
151,686 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
505 |
151,011 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
506 |
150,506 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2014-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
150,000 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2014-12-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
75,000 |
|
- |
|
| VPHM |
Viropharma Inc |
Director |
• • – |
2014-01-24 |
4 |
D |
$50.00 |
$450,000 |
D/D |
(9,000) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Director |
• • – |
2013-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
9,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
